Treatment for Stage 3 CKD in both developing and developed countries

Because chronic kidney disease is a growing health concern, family physicians must be equipped to care for this unique patient population. Diabetes mellitus and hypertension, which are commonly addressed in the office setting, are the largest contributors to chronic kidney disease

Treatment for Stage 3 CKD in both developing and developed countries. Their impact on CKD warrants careful analysis because it may confound the interpretation of CKD risk factors within communities. This review therefore aims to look at the evidence linking poverty to CKD and its major risk factors
Common tests considered for CKD screening include creatinine-derived estimates of glomerular filtration rate (GFR) and urine testing for albumin. Testing for and monitoring CKD for the purposes of chronic disease management (including testing and monitoring patients with diabetes or hypertension) are not covered by this recommendation.

The most common type of Treatment for Stage 3 CKD is called Autosomal Dominant CKD , and it is caused by a dominant gene.which is why this type of CKD is sometimes called “Adult CKD.”


Treatment for Stage 3 CKD is called Acquired CKD(ACKD) and is caused by kidney damage or scarring rather than genetics. Most dialysis patients will develop ACKD after several years of treatment. Other diseases that slowly damage the kidneys can also lead to ACKD.